Leiomyoma, popularly called fibroid, is a benign smooth muscle tumor of the uterus. Although non-cancerous, its growth within the uterine wall can cause heavy bleeding, pelvic pressure, and fertility problems. Like silent architects, these tumors remodel the uterus—often unnoticed until they cause significant symptoms.
🔄 Overview of Leiomyoma
Leiomyomas are benign neoplasms of smooth muscle origin, arising from the myometrium. They are estrogen-dependent and regress after menopause. Their size and number vary, with some growing large enough to distort the uterine cavity.
Core Features
- Nature: Benign smooth muscle tumor
- Origin: Myometrium
- Hormone Dependence: Estrogen-sensitive
- Behavior: May enlarge during pregnancy
Epidemiology
- Prevalence: Most common tumor in women
- Age: 30–50 years
- Risk Factors: Early menarche, obesity, estrogen therapy
- Regression: After menopause
🧬 Pathophysiology: Hormonal Growth and Fibrosis
Leiomyomas develop through estrogen and progesterone stimulation, leading to proliferation of smooth muscle and deposition of fibrous tissue. Genetic mutations such as MED12 are commonly implicated. Over time, degeneration and calcification may occur as the tumor outgrows its blood supply.
Estrogen-Dependent Growth
- Increased estrogen stimulates proliferation
- Growth during pregnancy
- Regression after menopause
Fibrotic Remodeling
- Excess extracellular matrix
- Firm, rubbery texture
- Calcification in older lesions
Vascular Changes
- Reduced perfusion → degeneration
- Possible infarction during pregnancy
- Pain from ischemic necrosis
💧 Clinical Features
Symptoms depend on size, number, and location. Many women are asymptomatic, while others experience severe bleeding or reproductive challenges.
Common Manifestations
General
- Heavy menstrual bleeding (menorrhagia)
- Pelvic pressure or pain
- Enlarged, irregular uterus
Location-Specific
- Submucosal: Bleeding, infertility
- Intramural: Uterine enlargement
- Subserosal: Pressure on bladder or rectum
🔬 Diagnosis
Diagnosis relies on clinical findings supported by imaging and histopathology.
| Test | Purpose | Findings |
|---|---|---|
| Pelvic Ultrasound | Primary imaging | Hypoechoic, well-defined mass |
| MRI | Assess size, number, and relation | Mapping for surgery |
| Histology | Confirm diagnosis | Whorled bundles of smooth muscle cells |
🎯 Management & Treatment
Treatment depends on symptoms, size, and fertility desires.
Medical Therapy
- GnRH agonists (reduce size)
- Progestins or OCPs (control bleeding)
- Tranexamic acid for menorrhagia
Surgical Options
- Myomectomy (fertility preservation)
- Hysterectomy (definitive)
- Uterine artery embolization
⚠️ Complications & Prognosis
- Complications: Anemia, infertility, miscarriage
- Malignant Transformation: Rare (<1%)
- Prognosis: Excellent; benign with minimal recurrence after menopause
🧠 Key Takeaways
- Leiomyoma is a benign, estrogen-dependent uterine tumor.
- Most common in women of reproductive age.
- Symptoms: Heavy bleeding, pelvic pain, infertility.
- Diagnosis: Ultrasound and histology.
- Treatment: Hormonal therapy, myomectomy, or hysterectomy.
- Prognosis: Benign with spontaneous regression after menopause.
🧭 Conclusion
Leiomyoma, though benign, embodies the delicate hormonal harmony of the uterus. Driven by estrogen and nourished by progesterone, these fibroids can disrupt fertility and well-being. Yet with timely diagnosis and tailored management, their impact can be minimized—preserving both health and womanhood.
Leiomyoma is a benign rhythm of muscle and hormone—peaceful in most, but disruptive when it grows unchecked.